X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    Wall Street Cautiously Optimistic After Gene Therapy Deals

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    Wall Street Cautiously Optimistic After Gene Therapy Deals

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

PCI Services Expanding of Cryogenic Storage Facilities at our Rockford, IL Site

Yuvraj_pawp by Yuvraj_pawp
18th November 2016
in Americas, Projects

PCI Services are pleased to announce that we are extending our current Cryogenic storage capabilities to our Rockford , Illinois operations, complementing the specialized capability currently offered at our Bridgend, UK center of excellence for Clinical Trial Services.


This investment was made in support of the changing needs of the pharmaceutical and biotech market and delivers an enhanced, robust facility for clients to store temperature-sensitive products, as well as offering critical dual site opportunities for clients’ cell banks and temperature-sensitive materials.

PCI’s significant market-leading Cold Chain, Ultra-Cold Chain and Cryogenic capabilities has enabled us to provide these innovative temperature-managed solutions to help reduce potential logistical and technical challenges with packaging, labelling, storage and distribution of drug products at cryogenic temperatures – demonstrating our ongoing commitment to developing our Clinical Trial services solutions for the benefit of our clients across the world.


PCI provides a highly specialized network capability for supporting temperature-sensitive drug product including Ultra-Cold Chain, at temperatures ranging from Controlled Ambient 15-25°C, 2-8°C, down to -20°C, -30°C -40°C, -60°C to -90°C, and including liquid nitrogen vapour phase storage at -196°C for Advanced Therapeutic Medicinal Products (ATMPs), as well as bespoke refrigerated and frozen temperatures according to client needs.


This added capability to our US operations is the latest in a series of major investments by PCI in supporting Clinical Trial supply, and follows our most recent announcement of the expansion of our Bridgend site with a purpose-built and dedicated -40°C facility; as well as a broader Cold Chain capacity expansion that increased site storage by over 400%; in addition to continued expansion of frozen storage at -80°C. The Rockford development, combined with the expansion in Bridgend, reflects PCI investments at other UK and North American sites, supporting specialized services for Clinical Trials and its considerable business growth in this segment.


The new specialization is situated in the 93,000 square feet Logistics Parkway building at the PCI Rockford campus, a purpose-built facility supporting Clinical Trials storage and distribution in 2015. The site is one of seven facilities at the Rockford center of excellence.


Brian Keesee, Executive Director, Clinical Services at PCI, said: “We are excited to expand our existing Cryogenic expertise in Bridgend into the US. Over the last decade, PCI has been actively involved in expanding its experience and specialized knowledge across the segment of gene therapies, somatic cell therapies and ATMPs. The new facility is an example of our dedication to testing and validating the newest technologies and storage capabilities to ensure they are using the most effective methods for clients.”


“We have a proven track record with dry ice and nitrogen shipping and storage systems, an extensive global distribution network and expertise in handling, storage and distribution of temperature-sensitive products. PCI’s continued investment in this area allows our clients to realize a safe and secure supply chain, ensuring their life-saving treatments are stored safely for patients around the world with the highest degree of confidence and assurance.”

Tags: America
Previous Post

Berkeley Lab provides X ray 3-D Imaging Technique Maps Migration of DNA-carrying Material

Next Post

Bionor Pharma announces acquisition of Solon Eiendom

Related Posts

Cellbox Solutions Establishes Subsidiary in the USA
Americas

Cellbox Solutions Establishes Subsidiary in the USA

24th September 2021
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
Americas

US Allows Johnson & Johnson Covid Vaccination To Resume

26th April 2021
POINT Biopharma to Launch First US Manufacturing Facility in Indiana
Americas

POINT Biopharma to Launch First US Manufacturing Facility in Indiana

5th June 2020
AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand
Americas

AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand

5th May 2020
Lilly to invest $400m to boost manufacturing capacity in US
Americas

Lilly to invest $400m to boost manufacturing capacity in US

26th November 2019
AI-based drug development
Americas

Janssen partners with nference for AI-based drug development

15th June 2019
Next Post

Bionor Pharma announces acquisition of Solon Eiendom

Latest News

Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
CPhI Pharma Index Shows Unprecedented Global Pharma Optimism
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In